Coproporphyrin analysis was performed on urine from 17 male and 7 female premature infants (birth wt 1.5-4.5 kg, average 1.7 kg). Six specimens of amniotic fluid obtained before elective abortion induced by saline solution infusion were also examined. Normal adult control subjects excreted 24.6y0 5.6y0 of total coproporphyrin as coproporphyrin I. Twenty-three premature infants excreted 59.4y0 A 17.3%
Introduction
Porphyrins exist in nature as I and I11 isomers. Isomer I porphyrins are excretory products without known function. Isomer I11 porphyrins are precursors of heme. Both isomers are produced primarily in liver and bone marrow and are found normally in urine and feces [12] . Coproporphyrin excretion in urine has been studied in adults [2, 3, [8] [9] [10] [11] 181 , but not in infants or amniotic fluid.
Methods
Total coproporphyrin excretion was determined spectrophotometrically in random urine specimens according to the method of Rimington [14, 151 as modified by Ben-Ezzer et ul. [3, 181. Creatinine concentration in urine was determined by the alkaline picrate method, and micrograms of coproporphyrin per gram of creatinine were determined. Assuming excretion in urine of 8 mg of creatinine/kg/24 hr in infants [l, 191 and 20 mg/kg/24 hr in adults [4] , micrograms of coproporphyrin excreted per kilogram per day were calculated. From standard tables [5] , using height and weight of each individual, surface area (in square meters) was estimated, and micrograms of coproporphyrin per square meter per day were calculated. On repeated assay of a single specimen, total coproporphyrin excretion in urine was within 14% of the mean.
Coproporphyrin isomers I and I11 were separated by thin layer chromatography (Uniplate Silica Gel G-250) by a modification of the method of Jensen [3, 6, 181 and the relative percentage of the two isomers was calculated [3] . T h e average R, was 0.17 for coproporphyrin I, and 0.23 for coproporphyrin 111. Repeated coproporphyrin determinations of single specimens were within 1.4% of the mean. Statistical analysis was performed with the use of Student's t test [17] .
Coproporphyrin analysis was performed on urine from 17 male and 7 female premature infants (birth wt Results of coproporphyrin studies are summarized in Table I and are expressed as mean t SD. Normal adult control subjects excreted 24.6% t 5.6% of total coproporphyrin as coproporphyrin I. Twenty-three premature infants excreted 59.4% t 17.3% as coproporphyrin I, an amount significantly higher than control subjects (P < .001). T h e proportion of coproporphyrin I in six specimens of amniotic fluid was 84.9 * 10.4%, significantly higher than in urine from adults and premature infants ( P < 0.001).
As reported previously [18] , patients with D-JS excreted 88.9% * 5.0% as coproporphyrin I, an amount significantly higher than control subjects (P < 0.001).
Obligate lieterozygotes excreted 31.6% t 5.9% as coproporphyrin I, intermediate between control subjects and D-JS patients (P < 0.001).
Total coproporphyrin excretion in urine in control Coproporphyrin I excretion in control subjects was 9.3 t 4.5 pg/m2/24 hr. This was not significantly different in premature infants (11.2 t 8.4 pg/m2/24 hr, P > 0.2) or in obligate heterozygotes (6.9 t 3.3 pg/m2/24 hr, P > 0.05). Coproporphyrin I excretion was significantly higher in D-JS patients (37.0 -+ 15.4 pg/m2/24 hr) than in control subjects (P < 0.001).
Coproporphyrin 111 excretion in control subjects was 28.5 t 10.8 pg/m2/24 hr. This was significantly lower in premature infants (6.3 t 5.3 pg/m2/24 hr, P < 0.001), in D-JS patients (4.5 t 2.6 pg/m2/24 hr, P < 0.001), and in obligate D-JS heterozygotes (15.4 t 9.8 pg/m2/24 hr, P < 0.001).
Discussion
Amniotic fluid and urine from premature infants contain a large proportion of coproporphyrin I when compared with urine from normal adults. These findings could result from alterations in metabolic clearance or production of porphyrins. T h e coproporphyrin excretion pattern present in amniotic fluid as well as urine from premature infants may be secondary to circulating estrogens or other inhibitory hormones which increase coproporphyrin I excretion in urine by reduction of hepatic excretory function [7, 13, 161 . Increased coproporphyrin I in amniotic fluicl and urine from neonates may also result from immaturity of porphyrin metabolism producing a developmental defect similar to that seen as a life-long abnormality in patients with the D-JS [3, 11, 181 . This syndrome results from defect in hepatic excretion of certain organic anions, and is characterized uniquely by [18] . T h e observations in amniotic fluid and urine from neonates are similar and may result from developmental immaturity of an enzyme (or enzymes) such as uroporphyrinogen I11 cosynthetase which regulates conversion of porphobilinogen to the I11 rather than the I isomer series. Developmental deficiency of this enzyme may be responsible for the observed pattern of coproporphyrin isomers seen in the fetus and neonate.
